This policy brief explores the dangerous potential of neuroweapons, the need for a “Neuroshield” to protect democracies from the risks of disinformation, the implications of brain-computer interfaces and other national security considerations related to brain health.
Harris A. Eyre, William Hynes, Geoffrey F. L. Ling, Jo-An Occhipinti, Rym Ayadi, Michael D. Matthews, Ryan Abbott, Patrick LoveAugust 10, 2023
Economic security has become a top priority for the West following the disruptions caused by COVID-19, the Russia-Ukraine war and the growing threat of China. Could investing in brain capital help build more resilient economies?
William Hynes, Paweł Świeboda, Patrick Love, Jo-An Occhipinti, Harris A. EyreAugust 2, 2023
The high-growth, high-tech sector appears poised to dramatically grow. U.S. policy to support this sector could enhance and hasten its rise, or could destroy a new American dream.
To harness the power of the market for ideas, the federal government must fund the U.S. patent office to 21st century levels and enhance the rights of patent owners.
High cancer drug prices significantly contribute to health care costs in the United States, with the average annual price of new cancer drugs increasing from less than $10,000 before 2000 to $145,000 in 2015. Baker Institute fellows Hagop M. Kantarjian and Vivian Ho highlight this issue and propose possible solutions.
The federal government will need a nuanced approach to properly stimulate small business growth. However, a core
focus should be on creating a level playing field for community banks to compete to provide small business loans.